ArticleCureus2025
Calciphylaxis: Beating the Odds.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calciphylaxis is an obliterative vasculopathy characterized by ischemic cutaneous necrosis secondary to the calcification of small- and medium-caliber blood vessels. This condition poses a significant therapeutic challenge and is often associated with poor outcomes. We report the case of a 59-year-old man who had been on renal replacement therapy for 28 years and presented with a painful necrotic ulcer on his left leg, which progressively worsened over three weeks. A skin biopsy confirmed the diagnosis of calciphylaxis. The treatment approach included intensified hemodialysis, optimization of mineral and bone disorder management, treatment of secondary bacterial infection, intravenous sodium thiosulfate infusion, chemical and surgical debridement, and partial-thickness skin grafting. This comprehensive strategy resulted in complete wound healing within three months. This case highlights the importance of early diagnosis and a multidisciplinary approach in managing calciphylaxis, a rare condition associated with a highly unfavorable prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.